AU Patent

AU2007323725A1 — Imidazotriazines and imidazopyrimidines as kinase inhibitors

Assigned to Incyte Holdings Corp · Expires 2008-05-29 · 18y expired

What this patent protects

Patent listed against capmatinib-hydrochloride.

Drugs covered by this patent

capmatinib-hydrochloride (CAPMATINIB HYDROCHLORIDE)

Patent Metadata

Patent number: AU2007323725A1
Jurisdiction: AU
Classification: —
Expires: 2008-05-29
Drug substance claim: No
Drug product claim: No
Assignee: Incyte Holdings Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.